January 29, 2024
Beximco Pharmaceuticals Limited, also called Beximco Pharma, is one of the leading pharmaceutical companies in Bangladesh. The renowned company is known for its commitment to excellence and access to affordable medicines. It is also raising global healthcare standards. By giving strong emphasis on research and development, Beximco Pharma has steadily marked its presence in the global industry. Its state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of the USA, Australia, European Union, Canada, and Brazil, among others.
Early Beginnings and Vision
Beximco Pharmaceuticals started its journey as a small-scale manufacturer in 1976 with a vision to become a global player in the pharmaceutical industry. The company soon expanded its lines of products, driven by a passion for innovation, quality, and customer satisfaction.
Research and Development Excellence
Beximco Pharma's success lies its commitment to extensive research and development. The company has invested significantly in building state-of-the-art R&D facilities and assembling a team of highly skilled scientists and researchers. These highly skilled scientists and researchers' focus on innovation has allowed them to develop a wide range of generic and branded pharmaceutical products, including complex generics and biosimilars, catering to more than 500 products encompassing broad therapeutic categories. The company has also created strong differentiation by offering a range of high-tech, specialized products that are difficult to imitate. Over the years, the research and development wing has grown into the country’s one of the most advanced ones.
Manufacturing Unit
Beximco Pharmaceuticals is spread across 23 acres in Dhaka, with an infrastructure to manufacture tablets, capsules, intravenous fluids, liquids, creams, ointments, suppositories, metered dose inhalers, ophthalmic drops, large volume parenteral, sterile ophthalmic, prefilled syringes, lyophilized injectables, etc. The infrastructure can generate and distribute 15 MW of electricity and has water-purifying and liquid nitrogen production capabilities. Beximco Pharma has over 4,700 employees, including 1,500 professionals including pharmacists, chemists, doctors, engineers, microbiologists, researchers, and business graduates. In 2018, Beximco Pharma acquired a majority stake in Nuvista Pharma (formerly Organon Bangladesh), a leading hormone and steroid manufacturer in the country. In 2021, the Company acquired a majority stake (54.6%) in Sanofi Bangladesh Limited, a subsidiary of global pharmaceutical giant Sanofi Group. Sanofi Bangladesh Limited was renamed Synovia Pharma PLC on April 01, 2022.
Innovation and Technology Adoption
Beximco Pharmaceuticals has always prioritized technological advancements to improve manufacturing capabilities and product quality. The company has invested in state-of-the-art facilities adhering to global standards and has incorporated innovative technologies such as continuous manufacturing and sterile lyophilization. These advancements have not only enhanced its product efficacy but also promoted environmental sustainability and cost-effectiveness.
Global Reach and Regulatory Compliance
Beximco Pharma's world-class quality products have marked its presence in over 50 countries, which includes the United States, Europe, Asia, Africa, and all the Latin American continent. The company's commitment to follow regulatory compliance is evident through its multiple accreditations and certifications, including the USA, Australia, European Union, Canada, and Brazil. These achievements have propelled Beximco Pharmaceutical's growth and earned recognition as a reliable and trusted supplier of high-quality pharmaceuticals worldwide.
Strategic Partnerships and Collaborations
Beximco Pharma has strong partnerships with renowned global pharmaceutical companies and research institutions like Eli Lilly, Novartis, and Gilead Sciences. These partnerships have facilitated knowledge and technology sharing, access to the global market, and its commitment to leveraging expertise and resources to deliver cutting-edge healthcare solutions.
Sustainable and Socially Responsible Practices
Beximco Pharma recognizes the importance of sustainability and actively integrates environmentally friendly practices into its operations. The company has implemented measures to reduce carbon emissions, conserve energy, and minimize waste generation. Moreover, it is dedicated to corporate social responsibility. For this reason, it contributes to community development through various initiatives, healthcare awareness programs, education, and disaster relief efforts.
Awards and Recognitions
Beximco Pharma's commitment to excellence and dedication to improving global healthcare has been acknowledged through numerous awards and recognitions, such as the Global Generics and Biosimilars Award in 2021 and 2022, National Export Trophy in the fiscal year 2020-21, Bangladesh Business Award, and Asia's Best Employer Brand Award. These recognitions validate its relentless pursuit of quality and contribution to the pharmaceutical industry.
Conclusion
Beximco Pharmaceuticals is a pioneering force in the global pharmaceutical sector, through its unwavering dedication to research, cutting-edge manufacturing, strategic partnerships, and a commitment to sustainability. The company has become a trusted supplier in over 50 countries. The number is expected to increase in future. Its emphasis on innovation, technology, and social responsibility reinforces its standing as an industry leader, receiving recognition through prestigious awards. Beximco Pharmaceuticals epitomizes the fusion of excellence, innovation, and global impact in the pharmaceutical sector.
